BioCentury
ARTICLE | Company News

Crucell, GlaxoSmithKline deal

April 12, 2010 7:00 AM UTC

Crucell and GSK partnered to develop a second-generation malaria vaccine. Crucell will contribute its AdVac Ad35-CS recombinant malaria vaccine, and GSK will contribute its Mosquirix malaria vaccin...